Cardiac Wire #205 August 29, 2024
Leqvio Monotherapy | TCM for Arrhythmia
Cardiac Wire #204 August 26, 2024
Tirzepatide Impact | Olpasiran Makes Waves
Cardiac Wire #203 August 22, 2024
J&J’s HFrEF Expansion | Edwards’ AR Acquisition
Cardiac Wire #202 August 19, 2024
Medicare Cuts | Hollywood Heart Attacks
Cardiac Wire #201 August 15, 2024
Rivus HU6 HFpEF Potential | A Case for HF Specialists
Cardiac Wire #200 August 12, 2024
Cardiology AI Clearances | CVAUSA’s Home Expansion
Cardiac Wire #199 August 8, 2024
Kerendia’s HF Impact | Heart Band-Aid
Cardiac Wire #198 August 5, 2024
Tirzepatide’s HFpEF Impact | Lp(a)’s Testing Lag
Cardiac Wire #197 August 1, 2024
Obicetrapib Cuts LDL-C | First Total Artificial Heart
Cardiac Wire #196 July 29, 2024
Edwards Acquisition Spree | Wegovy’s EU Expansion
Cardiac Wire #195 July 25, 2024
Magenta’s MCS Disruption | REVIVED CAD Evidence
Cardiac Wire #194 July 22, 2024
AFib Wearables’ Psychological Impact | Interactive Plaque
Cardiac Wire #193 July 18, 2024
Lexeo’s FA Cardiomyopathy Promise | Edwards Mitral Mission
Cardiac Wire #192 July 15, 2024
Huge Concurrent Settlement | Just Get the ECG | Life After MI
Cardiac Wire #191 July 11, 2024
Cardiology Deserts | Farapulse Safety
Cardiac Wire #190 July 8, 2024
Aging and Asymptomatic VHD | Private Equity’s Cardiology Expansion
Cardiac Wire #189 July 1, 2024
Cardiology in H1 2024 | Amvuttra’s ATTR-CM Impact
Cardiac Wire #188 June 27, 2024
Regenerating The Myocardium | Zerlasiran’s LP(a) Potential
Cardiac Wire #187 June 24, 2024